-
Clinical Trials Regulatory and Funding Information by EU-LAC PerMed
28 July 2023 – One of the activities of the EU-LAC PerMed project was the Virtual Helpdesk for clinical trials regulatory and funding information. It aimed to provide information on regulatory and funding agencies regarding clinical trials in Latin America and Europe, and to facilitate the establishment of partnerships in clinical trials on Personalised Medicine…
-
New Review Paper on European PM perspective
27 July 2023 – In September 2022, the conference “Cutting-Edge Implementation of Precision Medicine in Europe” took place in Stockholm, Sweden. All presenters, including ICPerMed chair Ejner Moltzen, provided input to a review/status paper on PM that is now published in the Journal of Internal Medicine.
-
Third ICPerMed Training Event on September 22nd
20 July 2023 – ICPerMed is happy to announce the 3rd “ICPerMed Training – Research Infrastructures in Personalised Medicine: use, advantages and challenges” which will take place on September 22nd, from 09:00 to 17:30, virtually. Applications will be accepted till September, 18th 12:00 o’clock CEST.
-
ICPerMed State of the Art Report 2022 published
30 June 2023 – The ICPerMed State of the Art Report 2022 is published and provides information about ICPerMed’s activities, the upcoming European Partnership for Personalised Medicine (EP PerMed) and activities in the field of Personalised Medicine.
-
Overcome Barriers in Personalised Medicine Research
14 June 2023 – One aim of ICPerMed is to accelerate the translation and implementation of results of personalised medicine (PM) research projects. In order to understand the barriers and gaps currently encountered by researchers, the ICPerMed Secretariat conducted and analysed a survey with researchers from PM projects. The results of the analysis, including potential…
-
ICPerMed Brief ‘Optimizing Clinical Research for Personalised Medicine: Recommendations for Funders, Regulators and Policy Makers’
22 May 2023 – ICPerMed published a set of recommendations for optimizing personalised medicine (PM) related clinical research as a brief specifically addressed to policy, funding bodies and regulatory agencies. These recommendations have been elaborated by the ICPerMed Working Group „Clinical Studies in Personalised Medicine“ together with the CSA PERsonalised Medicine Trials project, PERMIT. PM-related…
-
Publication of the Strategic Research and Innovation Agenda for Personalised Medicine
28 April 2023 – ICPerMed is happy to announce the publication of the Strategic Research and Innovation Agenda (SRIA) for Personalised Medicine (PM). This SRIA will support a wide range of stakeholders and experts to further develop programs, activities, and research towards PM and care, as well as prevention. In line with this mission, its…
-
Open Access in Personalised Medicine
24 March 2023 – Open Science and Open Access are key aspects of the Responsible Research and Innovation (RRI) approach. It provides online, free, re-usable and shared access to scientific information (peer-reviewed scientific research articles and research data). In order to implement open access policies and data integration of research data into European databases, ICPerMed…
-
Report on SRIA consultation for EP PerMed
13 March 2023 – Publication of the report on the open consultation for the Strategic Research and Innovation Agenda (SRIA) in support for the European Partnership for Personalised Medicine, EP PerMed.
-
EU-Africa PerMed Webinar: Health Technology Assessment under Personalised Medicine
09 March 2023 – Health Technology Assessment (HTA) on personalised medicine focuses on assessing the effectiveness, safety, and cost-effectiveness of diagnostic tools and treatments tailored to individual patients based on their genetic, environmental, and lifestyle factors. HTA can provide important information to support decision-making in the adoption, funding, and use of these technologies in clinical…
